Bruker Announces Major Order of Advanced Magnetic Resonance Systems at Max Planck Institute for Solid State Research
BILLERICA, Massachusetts – October 24, 2025 – Bruker announces the order of multiple advanced Magnetic Resonance systems at the Max Planck Institute for Solid State Research (MPI-FKF) in Stuttgart, Germany. This major investment positions MPI-FKF as a European leader in battery research infrastructure. It will provide the Electrochemical Materials Department, led by Prof. Raphaële Clément, with cutting-edge NMR and EPR technology to accelerate breakthroughs in next-generation battery materials and energy storage solutions.
The Max Planck Institute for Solid State Research has acquired two Avance Neo 800 MHz and one Avance Neo 100 MHz NMR systems, each equipped with a suite of solid state and diffusion probes tailored for battery research, as well as a state-of-the-art E580 FT/CW EPR spectrometer with modern multi-harmonic detection. Nuclear Magnetic Resonance (NMR) and Electron Paramagnetic Resonance (EPR) are powerful analytical techniques that allow scientists to observe the structure, dynamics, and chemical processes within battery materials at the atomic and molecular level. The new NMR and EPR systems will enable the MPI-FKF team to perform real-time (operando) studies of electrodes and electrolytes, investigate ion transport and diffusion, and monitor phase transitions and degradation mechanisms. By harnessing these capabilities, the researchers aim to accelerate the development of innovative energy storage solutions with greater performance, safety, and sustainability, supporting the global shift toward cleaner energy.
Prof. Raphaële Clément, Head of the Electrochemical Materials Department at MPI-FKF, commented: “These advanced Bruker instruments will significantly expand our ability to investigate complex battery materials and processes. With enhanced sensitivity and resolution, we can now study a broader range of chemistries, including materials with low-abundance nuclei and Earth-abundant elements, such as oxide and sulfide conversion-type electrodes. These new capabilities will help us uncover mechanisms for higher energy densities and longer-lasting batteries. They also enable us to address key questions about how cycling conditions and material interfaces impact battery performance and durability.”
Dr. Falko Busse, President of Bruker BioSpin Group, added: “We are proud to support the Max Planck Institute for Solid State Research in their pursuit of groundbreaking battery research. This order reflects Bruker’s commitment to providing world-class scientific instrumentation and exemplifies our strategic focus on enabling scientific progress through advanced Magnetic Resonance technologies.”
Once installed, MPI-FKF will be positioned to make significant advances in battery science, contributing to the development of safer, more efficient, and sustainable energy storage solutions. The research enabled by Bruker’s technologies will help address global energy needs and support the transition to a cleaner energy future.
About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)
Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.
Media Contact
Markus Ziegler
Sr. Director and Head of Group Marketing
Bruker BioSpin
T: +49 172 3733531
E: pr@bruker.com